Skip to content

Comparing of the effect of" Ginger-Lavender" capsule with" Mefenamic Acid" on postpartum pain

Comparing of the effect of" Ginger-Lavender" capsule with" Mefenamic Acid" on postpartum pain

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200525047565N3
Enrollment
94
Registered
2021-11-12
Start date
2021-11-22
Completion date
Unknown
Last updated
2021-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postpartum pain.

Interventions

Intervention 1: Intervention group: "Ginger-lavender" group of 300 mg capsules containing 250 mg of ginger and 50 mg of Lavender extract prepared in Shahid Beheshti School of Traditional Medicine 4 t

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
15 Years to 44 Years

Inclusion criteria

Inclusion criteria: Be 15 to 44 years old Have minimum literacy Have vaginal delivery Be in 37 to 42 weeks of gestational age Complain of moderate to severe postpartum pain Do not have the delivery with the help of tools Have no 3rd and 4th degree rupture No history of chronic or systemic diseases such as diabetes or high blood pressure Have no history of cesarean section and intra-abdominal surgery Do not use epidural and spinal anesthesia during labor Do not have any drug addiction Have no history of allergies to herbal medicines Successful breastfeeding has begun Have a singleton delivery and healthy baby Have no complications of childbirth such as bleeding, fever and high blood pressure Have a history of more than one delivery

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Severity of pain. Timepoint: 2 hours after delivery, To be evaluated every 6 hours before and one hour after the intervention until 24 hours after delivery. Method of measurement: Visual analog scale.

Countries

Iran (Islamic Republic of)

Contacts

Public Contactsharareh Jannesari

Shahid Beheshti University of Medical Sciences

shararehjannesari@gmail.com+98 21 8865 5366

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026